Market Closed

XTLB
XTL Biopharmaceuticals Ltd.
$ 1.60
-2.44%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

XTL Biopharmaceuticals Ltd. News

Latest XTL Biopharmaceuticals Ltd. Stock News & XTLB Headlines

XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) Short Interest Update
a month ago | defenseworld.net
XTL Biopharmaceuticals (NASDAQ:XTLB) Shares Pass Above Fifty Day Moving Average – Here’s Why
3 months ago | defenseworld.net
XTL Completed the Acquisition of Psyga Bio Ltd.
5 months ago | globenewswire.com
XTL Announces Receipt of Staff Delist Determination from Nasdaq
6 months ago | globenewswire.com
XTL Announces Receipt of Staff Delist Determination from Nasdaq
6 months ago | globenewswire.com
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
7 months ago | globenewswire.com
XTL Biopharmaceuticals Announces ADS Ratio Change
8 months ago | globenewswire.com
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
9 months ago | globenewswire.com
XTL Update on Recent Developments
10 months ago | globenewswire.com
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
10 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

XTLB
XTL Biopharmaceuticals Ltd.
$ 1.60
-2.44%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago